Pineal Gland

The Pineal Gland: A Comprehensive Reference

Overview and Historical Context

The pineal gland is an endocrine gland located in the posterior aspect of the cranial fossa in the brain. Also called the pineal body or epiphysis cerebri, it is a tiny gland located beneath the back part of the corpus callosum. The anatomical descriptions of Andreas Vesalius (1515–1564) formed the basis for the conceptualization of the pineal gland as the "seat of the soul" by René Descartes (1596–1650). The pineal gland is the least understood gland of the endocrine system, and it was the last part of the endocrine system to be discovered.

Anatomy and Structure

The gland is pine-cone shaped and about 0.8 cm long; in an adult it weighs about 0.1 g and is unpaired, located between the thalamic bodies, behind the habenular commissure. The pineal gland projects posteriorly from the wall of the third ventricle above the quadrigeminal plate, resting in the groove between the two superior colliculi. It is located near the corpora quadrigemina, which is behind the third ventricle; cerebrospinal fluid bathes the gland through the pineal recess.

The pineal gland is a neuroendocrine organ that comprises a part of the epithalamus, one of the three divisions of the diencephalon. Other components of the epithalamus include the stria medullaris, habenular nuclei, posterior commissure, and paraventricular nuclei.

Cellular Composition

In humans, the main cell types are pinealocytes (95%) along with scattered glial cells (astrocytic and phagocytic subtypes). Microscopically, the gland is composed of pinealocytes — rather typical endocrine cells, except for extensions that mingle with those of adjacent cells — and supporting cells similar to the astrocytes of the brain.

Vascular Supply and Innervation

The principal innervation is sympathetic, arising from the superior cervical ganglia. Arterial vascularization of the pineal gland is supplied by both the anterior and posterior circulation, with the main artery being the lateral pineal artery, which originates from the posterior circulation. Because the gland lacks a blood-brain barrier, it shows avid enhancement with gadolinium on imaging.

Physiological Functions

Melatonin Synthesis: The Primary Function

The main function of the pineal gland is to receive information about the state of the light-dark cycle from the environment and convey this information by the production and secretion of the hormone melatonin. The pinealocyte cells that make up the pineal gland are known to produce and secrete the amine hormone melatonin, which is derived from serotonin. The pinealocytes create melatonin and secrete it directly into the cerebrospinal fluid, the fluid that flows in and around the hollow spaces of the brain and spinal cord, which then takes it into the bloodstream.

Melatonin is synthesized from the amino acid tryptophan via four sequential enzymatic steps: conversion of dietary amino acid tryptophan to 5-hydroxytryptophan (5-HTP) by tryptophan hydroxylase 1 (TPH1); synthesis of 5-hydroxytryptamine (5-HT or serotonin) by aromatic amino acid decarboxylase; formation of N-acetylserotonin (NAS) by arylalkylamine N-acetyltransferase (AANAT); and production of melatonin by hydroxyindole-O-methyltransferase (HIOMT).

The pineal gland is a photo-neuro-endocrine organ situated inside the brain that secretes serotonin, melatonin, and N,N-dimethyltryptamine. Both melatonin and its precursor serotonin, which are derived chemically from the alkaloid substance tryptamine, are synthesized in the pineal gland. Along with other brain sites, the pineal gland may also produce neurosteroids.

Light–Dark Signal Transduction and the SCN Pathway

Melatonin production is stimulated by darkness and inhibited by light. Light-sensitive nerve cells in the retina detect light and send this signal to the suprachiasmatic nucleus (SCN), synchronizing the SCN to the day-night cycle. Nerve fibers then relay the daylight information from the SCN to the paraventricular nuclei, then to the spinal cord, and via the sympathetic system to the superior cervical ganglia, and from there into the pineal gland.

The last neuron in the pathway, which has its soma situated in the superior cervical ganglion of the sympathetic nervous system, releases norepinephrine (NE) in the perivascular spaces of the pineal gland at night. NE binds to adrenergic receptors on the membrane of the pinealocyte and activates intracellular signaling pathways, resulting in nocturnal melatonin synthesis.

In humans, melatonin production is low during the day and begins to rise in the evening, approximately 2 hours before habitual bedtime, when the SCN clock signals the onset of night. Pineal melatonin levels then surge to a peak in the middle of the night (around 2–4 a.m. for a typical schedule), and fall rapidly toward morning as light inhibits further synthesis. The duration of melatonin secretion at night encodes night length (photoperiod), with longer winter nights allowing a more prolonged melatonin signal than short summer nights.

Pathological or traumatic sympathetic denervation — for example, injury to the spinal cord — of the pineal gland or administration of β-adrenergic antagonists abolishes the rhythmic synthesis of melatonin and the light-dark control of its production.

Circadian Rhythm and Sleep Regulation

Melatonin regulates the body's sleep-wake cycles by interacting with the suprachiasmatic nucleus of the hypothalamus and the retina. The best-known purpose of melatonin is its role in promoting sleep and inhibiting wake-promoting signals through interactions with its MT1 and MT2 receptors.

In mammals, circadian organization is dominated by the SCN, which serves as a "master pacemaker" in the control of a wide array of behavioral and physiological rhythms, including locomotion, sleep-wake, thermoregulation, cardiovascular function, and many endocrine processes.

Reproductive and Pubertal Regulation

The gland has several functions, the most important of which is maintaining the body's circadian rhythm and regulating the sleep-wake cycle. In addition, the pineal gland plays a role in modulating the onset of puberty and the development of the reproductive system. Both melatonin and its related hormones have been shown to be antigonadotrophic; however, it is unknown whether they directly suppress other gonadotrophic hormones or the gonadotropin hormones of the adenohypophysis.

Changing photoperiod is indicated by the duration of melatonin secretion and is used by photoperiodic species to time their seasonal physiology.

Antioxidant and Immune Properties of Melatonin

Melatonin is a pleiotropic molecule with anti-inflammatory, antioxidant, and anticoagulopathic properties in addition to its endothelial protective effects. Melatonin stimulates the function of the immune system via the production of interleukins (ILs), including IL-1, IL-2, IL-6, and IL-12, interferon-gamma, helper T cells, cytotoxic T cells, and B- and T-cell precursors. Melatonin is considered highly effective in reducing the effects of oxidative stress throughout the body and is considered to protect against oxidative stress-evoked DNA damage.

Assessment of Pineal Gland Health and Function

Measuring Melatonin Output

The rhythmic production of melatonin, normally secreted only during the dark period of the day, is extensively used as a marker of the phase of the internal circadian clock. Functional assessment of the pineal gland is therefore largely indirect, centered on measuring melatonin and its metabolites.

Melatonin is excreted in the urine principally as 6-sulfatoxymelatonin (aMT6s), the main metabolite, though a small amount of unmetabolized melatonin can also be found in the urine. Urinary melatonin assessment is more easily achieved with a single sample of first-morning urine, though more frequent collections (every 2–8 hours for 24–48 hours) help ensure accuracy; this measure can provide an assessment of the total nocturnal melatonin release.

Melatonin made in the pineal gland is distributed to the body through the blood, metabolized through the liver, and excreted as aMT6s in the urine. It is important to recognize that melatonin has a short half-life, between 20–60 minutes, in the blood, and blood samples only reflect the amount of melatonin circulating at the time of collection.

Volumetric and Imaging Assessment

In adults, small deposits of calcium often make the pineal body visible on X-rays; the pineal gland eventually becomes more or less calcified in most people. Pineal parenchyma, calcification, and cyst volumes can be calculated from brain magnetic resonance imaging (MRI). By using an innovative method for pineal assessment, pineal parenchyma volume has been found to be positively correlated with 6-sulfatoxymelatonin levels.

Factors That Support Normal Pineal Function

Melatonin is synthesized from tryptophan, an essential dietary amino acid. It has been demonstrated that some nutritional factors, such as intake of vegetables, caffeine, and some vitamins and minerals, could modify melatonin production, but with less intensity than light, the most dominant synchronizer of melatonin production.

Overall, foods containing melatonin or promoting the synthesis of it by impacting the availability of tryptophan, as well as those containing vitamins and minerals needed as co-factors and activators in the synthesis of melatonin, may modulate the levels of melatonin.

Behavioral and environmental factors are also primary determinants of pineal function. Exposure to light suppresses melatonin production and release from the pinealocytes, while darkness (when registered by the retina) increases melatonin production and release into the bloodstream. Consistent sleep schedules and minimizing bright light exposure in the evening hours are supported by physiological evidence as the most potent regulators of melatonin secretion.

Nutrients Studied in Relation to the Pineal Gland and Melatonin

Tryptophan

Biochemical Role: Melatonin is synthesized from tryptophan, an essential dietary amino acid. Tryptophan is an essential amino acid in humans. Humans cannot produce tryptophan sufficiently by themselves, so this amino acid must be absorbed from protein-rich foods (e.g., milk, eggs, meat, and beans). Tryptophan is metabolized into melatonin via the serotonin pathway.

Scientific Evidence: A laboratory-based study reported that melatonin secretion at night was significantly increased by consumption of a tryptophan-rich breakfast with daytime bright light exposure for 3 days, although the secretion was not significantly changed by consumption of a tryptophan-poor breakfast. Both field and laboratory-based studies indicated that melatonin secretion at night might be increased by tryptophan intake in the morning if there is exposure to bright light during the daytime. However, tryptophan supplementation alone, unlike exposure to daytime bright light, does not acutely affect biological rhythm and sleep in humans. Evidence is preliminary and context-dependent.

Magnesium

Proposed Role: Magnesium has been proposed as a cofactor in the melatonin synthesis pathway and as a regulator of GABA receptors involved in sleep.

Scientific Evidence: Reliable clinical evidence of boosted melatonin secretion following the ingestion of magnesium does not yet exist. In a study of 10 healthy men, a single intravenous dose of magnesium sulphate was found to have no effect on the release of melatonin. No correlation between serum magnesium and melatonin levels was found in patients with intervertebral disc herniation. Evidence for a direct melatonin-boosting effect of oral magnesium supplementation remains weak.

Zinc

Proposed Role: Zinc has been suggested to interact with pineal physiology and melatonin production.

Scientific Evidence: A clear positive correlation between serum zinc and melatonin level was found in one study. However, this is observational evidence, and the causal direction of any relationship between zinc status and pineal melatonin secretion has not been established in controlled clinical trials. Evidence remains preliminary and associative.

Polyunsaturated Fatty Acids (PUFAs)

Proposed Role:

The pineal gland contains high levels of n-6 and n-3 polyunsaturated fatty acids (PUFAs), especially arachidonic acid and docosahexaenoic acid (DHA). The functional significance of this lipid composition for pineal hormone synthesis in humans has not been established in clinical trials. Evidence is structural and preclinical only.

Herbs and Natural Ingredients Studied or Traditionally Used in Relation to the Pineal Gland

Most herbal and botanical interventions relevant to the pineal gland are studied for their effects on sleep, circadian rhythm, or stress — all systems substantially regulated by pineal melatonin output. No herb has been demonstrated in rigorous clinical trials to directly stimulate or protect the pineal gland itself; rather, evidence pertains to sleep quality outcomes or melatonin-adjacent mechanisms.

Valerian (Valeriana officinalis)

Traditional Use: Valerian has a long history of use in Europe as a sleep aid, and its root extract has gained popularity as an over-the-counter remedy for insomnia in the U.S. Traditional European herbal medicine used valerian root preparations for nervousness, restlessness, and sleep disturbances.

Proposed Mechanism: The flowering plant valerian (Valeriana officinalis), a commonly used herb for anxiety and sleep problems, contains valerenic acid, which activates chloride currents in certain GABA(A) receptors. Valerian activity on sleep disturbances has been attributed to the presence of isovaleric acids and valepotriates with reported calming action and GABA reuptake inhibition with sedative effects.

Scientific Evidence: Considering the data presented in the literature — despite controversial and conflicting results — several studies showed that valerian (160–600 mg/day) improved sleep quality and reduced sleep latency and duration; also, valerian seems more effective for chronic insomnia than acute episodes. A review of medicinal plants concluded that valerian is among the three plants with the most potential for insomnia, with the combination of valerian with hops and passionflower giving the best results in clinical tests. The evidence base is moderate in size but limited by heterogeneity of preparations and study designs.

Passionflower (Passiflora incarnata)

Traditional Use: Traditional herbalists have used passionflower as a sleep aid, especially when patients complained of restlessness. It has been used in European and North American herbal traditions as a sedative and anxiolytic.

Proposed Mechanism: Passionflower contains compounds that interact with GABA receptors, enhancing their inhibitory effects.

Scientific Evidence: Administration of NSF-3 — a mixture of valerian, passionflower, and hops — in patients with primary insomnia enhanced total sleep time and latency and decreased both the number of nightly awakenings and Insomnia Severity Index scores. Evidence for passionflower as a standalone treatment for insomnia remains limited; most positive findings come from combination products.

Ashwagandha (Withania somnifera)

Traditional Use: Ashwagandha (Withania somnifera) is a root used for centuries in Ayurvedic medicine and classified as an adaptogen — a substance that supports the body's ability to maintain equilibrium under stress.

Proposed Mechanism: Active compounds including withanolides, sitoindosides, and alkaloids modulate the hypothalamic-pituitary-adrenal (HPA) axis, inhibit NF-κB, induce Nrf2 activation, and affect GABAergic signaling, collectively contributing to anti-inflammatory, antioxidant, and anxiolytic actions.

Scientific Evidence: Participants with insomnia who took ashwagandha extract showed improvements in sleep quality, sleep onset latency, mental alertness on rising, and perceived anxiety symptoms compared with those taking placebo, as measured by actigraphy and validated rating scales. Serum cortisol levels reduced with both ashwagandha 250 mg/day and 600 mg/day compared to placebo. Participants receiving ashwagandha also had significant improvement in sleep quality. The main limitation of trials to date is their small sample sizes, necessitating larger trials to assess the benefits of ashwagandha. Evidence for sleep improvement and stress reduction is moderate; the precise mechanism of action on pineal melatonin production specifically has not been established.

Lemon Balm (Melissa officinalis)

Traditional Use: Lemon balm has been used in traditional European medicine for centuries as a calming herb for restlessness and sleep problems. Lemon balm is often combined with other herbs, such as valerian, in formulations aimed at sleep support.

Proposed Mechanism: Lemon balm contains compounds that interact with GABA receptors, enhancing their inhibitory effects.

Scientific Evidence: A clinical trial using lemon balm in combination with other botanical extracts found that the combination improved the symptoms of anxiety and depression and reduced insomnia as measured with the Insomnia Severity Index (ISI). Evidence for lemon balm as a monotherapy for insomnia is limited; most clinical data involve combination preparations.

Melatonin as a Supplement

Background: The use of melatonin supplements by adults in the United States more than quintupled between 1999 and 2018. Exogenous melatonin is not an herb, but is often grouped with natural sleep supplements given that it is the direct hormonal product of the pineal gland.

Scientific Evidence — Jet Lag and Circadian Disorders: Melatonin is used as a therapy for certain sleep disorders related to circadian rhythm abnormalities, such as delayed sleep phase syndrome, non-24-hour sleep-wake disorder, and jet lag. Sleep onset latency was decreased greatly in people with delayed sleep phase syndrome (weighted mean difference: −38.8 min; 95% CI: −50.3 min, −27.3 min), and the magnitude of this effect appears to be clinically significant.

Scientific Evidence — General Insomnia: According to practice guidelines from the American Academy of Sleep Medicine (2017) and the American College of Physicians (2016), there is not enough strong evidence on the effectiveness or safety of melatonin supplementation for chronic insomnia to recommend its use. A double-blind randomized clinical trial found that melatonin supplementation over a four-week period was effective and safe in improving some aspects of objective sleep quality — including total sleep time, percentage of rapid eye movement sleep, and early morning wake time — in middle-aged patients with insomnia.

Scientific Evidence — Pre-operative Anxiety: A 2015 review looked at 12 studies involving 774 people and assessed melatonin supplements for treating anxiety before surgery; the review found strong evidence that melatonin is better than placebo at reducing anxiety before surgery.

Scientific Evidence — Shift Work: According to two 2014 research reviews, studies on whether melatonin supplements help shift workers were generally small or inconclusive.

Safety Considerations: The actual content of melatonin in commercial supplements may be many times higher than what is listed on the label, raising safety concerns. Clinicians should exercise caution when considering melatonin supplementation for patients with autoimmune diseases, such as rheumatoid arthritis or post-organ transplant.

Conditions and Concerns Associated with the Pineal Gland

Pineal Gland Calcification

Calcification of the pineal gland is quite common. A calcified pineal gland is commonly used as a landmark on X-rays. Calcium and phosphate deposits are directly correlated with age. It is not yet known whether pineal gland calcification (PGC) is an age-associated physiological process or a pathological condition caused by lifestyle factors and metabolic dysregulations.

Some studies have demonstrated that the degree of calcification of the pineal gland is higher in those affected by Alzheimer's disease compared to conditions demonstrating other types of dementia. There is a loose correlation between the calcification of the pineal gland and some migraine and cluster headaches.

Reduced Melatonin with Aging

Natural melatonin levels decline with advancing age. The consolidated evidence that an efficient grade of neuronal trophism is needed to guarantee the mechanisms of brain adaptation and resilience to stressful conditions as well as during brain aging suggests that the supplement of exogenous melatonin may be effective to reinstate not only the altered sleep-wake cycle but also the reduced neuroprotective mechanisms during such uncomfortable conditions.

Disrupted Melatonin and Cancer Risk

Due to anti-estrogenic properties, melatonin is considered to exhibit a protective role against the development of breast cancer. Disruption of melatonin production through environmental influences — such as night work — is assumed to be a risk factor for breast cancer. Low urinary levels of 6-sulfatoxymelatonin have been associated with increased risk of advanced prostate cancer. Evidence for these associations is largely epidemiological; causality has not been definitively established.

Pineal Gland Tumors

Tumors of the pineal region account for approximately 3–11% of pediatric brain neoplasms but fewer than 1% of brain neoplasms in adults. Several different tumors can arise from the pineal gland. Diagnosis of the type of tumor is crucial for treatment. The primary symptom of the tumor is hydrocephalus.

Pineal parenchymal tumors such as pineocytoma and pineoblastomas typically demonstrate peripheral calcifications, whereas germ cell tumors tend to encompass the calcified pineal tissue. Many tumors of the pineal region may spread locally or seed distantly; therefore, a complete spinal MRI is often recommended as part of the initial evaluation.

The tumor's effect on the hypothalamus leads to weight gain and disruptions in sleep, temperature regulation, and water regulation. Cerebellar involvement would result in motor impairment. If a pineal gland tumor is present in childhood, endocrine dysfunctions can also result, such as precocious pseudopuberty, diabetes insipidus, and a slowed growth rate.

Pineal Cysts

Cysts were present in 59% of pineal glands in one MRI-based cohort study. Pineal calcification has been reported both to have no effect on melatonin levels and to have been associated with lower melatonin levels; the effect of pineal cysts on melatonin levels has only been reported for small case reports which differ in their findings. The clinical significance of incidentally discovered pineal cysts in the absence of neurological symptoms remains uncertain.

Circadian Rhythm Sleep-Wake Disorders

Pineal gland function and melatonin secretion can be impaired due to accidental and developmental conditions, such as pineal tumors, craniopharyngiomas, injuries affecting the sympathetic innervation of the pineal gland, and rare congenital disorders that alter melatonin secretion. Melatonin has shown efficacy in circadian rhythm sleep-wake disorders.

Absence of Classic Hormone-Deficiency Syndromes

In contrast to other endocrine glands such as the pituitary, adrenal, and thyroid, there are no well-defined pineal hormone-deficiency or hormone-excess syndromes. The lack of pineal disorders that involve hormone deficiency or hormone excess has been an obstacle to the investigation of putative roles for the gland. Such roles include the possibility that melatonin secretion is an important factor in the induction and maintenance of nocturnal sleep, as suggested by classical studies in night-shift workers.

References

• Ilahi S, Beriwal N, Ilahi TB. Physiology, Pineal Gland. StatPearls [Internet]. NCBI Bookshelf.
• Arendt J, Aulinas A. Physiology of the Pineal Gland and Melatonin. Endotext [Internet]. NCBI Bookshelf.
• Guleş O, et al. The morphological and functional characteristics of the pineal gland. PMC.
• Simonneaux V, Ribelayga C. Circadian Regulation of Pineal Gland Rhythmicity. PMC / NIH.
• Savage RA, et al. Melatonin. StatPearls [Internet]. NCBI Bookshelf.
• Oregon State University OpenStax. 17.7 The Pineal Gland – Anatomy & Physiology 2e.
• Encyclopædia Britannica. Pineal gland.
• Cleveland Clinic. Pineal Gland: What It Is, Function & Disorders.
• Hall WA, Karsonovich T. Pineal Gland Cancer. StatPearls [Internet]. NCBI Bookshelf.
• Ostrom QT, et al. Pineal Gland Tumors: A Review. PMC.
• Tan DX, et al. Revisiting the pineal gland: a review of calcification, masses, precocious puberty, and melatonin functions. PubMed.
• Tahamtani A, et al. Cross-sectional analysis of potential risk factors of the pineal gland calcification. BMC Endocrine Disorders.
• National Center for Complementary and Integrative Health (NCCIH). Melatonin: What You Need To Know.
• NIH Research Matters. Use of melatonin supplements rising among adults. (Li J et al., JAMA 2022).
• Buscemi N, et al. Melatonin for Treatment of Sleep Disorders: Summary. AHRQ Evidence Report Summaries. NCBI Bookshelf.
• Xie Z, et al. Efficacy of melatonin for sleep disturbance in middle-aged primary insomnia: a double-blind, randomised clinical trial. PubMed.
• Peuhkuri K, Sihvola N, Korpela R. Dietary factors and fluctuating levels of melatonin. PMC.
• Nakade M, et al. Can tryptophan supplement intake at breakfast enhance melatonin secretion at night? PMC.
• Sigurdardottir LG, et al. Pineal Gland Volume Assessed by MRI and its Correlation with 6-Sulfatoxymelatonin Levels among Older Men. PMC.
• Mucci LA, et al. Exploratory Assessment of Pineal Gland Volume, Composition, and Urinary 6-Sulfatoxymelatonin Levels on Prostate Cancer Risk. PMC.
• Tavakol HS, et al. Impact of a Novel Valerian Extract on Sleep Quality, Relaxation, and GABA/Serotonin Receptor Activity in a Murine Model. PMC.
• Nicolussi S, et al. A systematic review of effectiveness and safety of some herbal compounds as treatment for primary insomnia. PMC.
• Urech L, et al. Medicinal Plants for Insomnia Related to Anxiety. Planta Medica.
• NIH Office of Dietary Supplements. Ashwagandha: Is it helpful for stress, anxiety, or sleep? Health Professional Fact Sheet.
• Pratte MA, et al. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. PMC.
• Singh N, et al. Ashwagandha as an Adaptogenic Herb: A Comprehensive Review of Immunological and Neurological Effects. PMC.
• Padumanonda T, et al. Determination of melatonin content in traditional Thai herbal remedies used as sleeping aids. PMC.
• Drăgoi CM, et al. Rhythms of life: melatonin, nutrition, sleep, and antioxidant strategies for healthy aging. Frontiers in Neuroscience.